TCTR20190722005
Recruiting
Phase 3
The efficacy and safety of 0.5% topical timolol on corneometry and transepidermal water loss after ablative fractional CO2 laser for atrophic acne scars: a split face randomized double blind placebo-controlled trial
none0 sites25 target enrollmentStarted: July 22, 2019Last updated:
Overview
- Phase
- Phase 3
- Status
- Recruiting
- Sponsor
- none
- Enrollment
- 25
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 Years to 50 Years (—)
- Sex
- All
Inclusion Criteria
- •The participants aged 18\-50 years old with atrophic area scars for at least three months
Exclusion Criteria
- •1\) pregnant/lactating female, 2\) history of isotretinoin use within previous 3 months before enrollment, 3\) history of cosmetic procedures including botulinum toxin, filler, collagen, lasers within the preceding 3 months, 4\) history of photosensitivity or skin cancer, 5\) history of psoriasis, hypertension, or asthma, 6\) allergy to anesthetic agents, or timolol solution, 7\) active dermatitis or herpes infection (within previous 2 weeks), 8\) Fitzpatrick skin type V †VI, 9\) current or history of previous use within one month of anticoagulative drugs or NSAIDs use or previous use
Investigators
Similar Trials
Not yet recruiting
Phase 4
sefulness of Timolol in a condition of vascular overgrowth of tissueCTRI/2019/04/018581Indian Association of Dermatologists Venereologists and Leprologists Research grant
Completed
Not Applicable
Evaluation of a new substance (isobutylamido thiazolyl resorcinolcream) compared to the use of hydroquinone 4% cream to treat facial blemishesMelasmaRBR-87kphyFaculdade de Medicina de Botucatu (FMB - Unesp)
Recruiting
Phase 2
Evaluation of efficacy of Topical Timolol for treatment in conjunctival Pyogenic GranulomPyogenic granuloma.Pyogenic granulomaL98.0IRCT20160523028008N27Hamedan University of Medical Sciences46
Completed
Phase 1
To determine effectiveness of topical application of 0.5% Timolol Maleate in treatment of chronic heel recalcitrant fissuresIRCT20230712058759N1Pak Emirates Military Hospital150
Active, not recruiting
Phase 1
Study to evaluate efficacy and safety of topical administration of timolol maleate 0.5% solution in the treatment of Child Proliferative Hemangioma Early Stage SurfaceChildren Superficial HemangiomaTherapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]EUCTR2013-005199-17-ESInstitut de Recerca HSCSP70